We welcome interest from academic research institutions and commercial companies seeking access to our proprietary RNA therapeutics and delivery technology or to our therapeutic pipeline.
• We are keen to support academic research into RNA therapeutics through access to our materials
• One of very few companies able to provide human-validated RNAi to academics
• Also supply proven delivery systems for use with short interfering RNA or messenger RNA, in vivo
• Comprehensive RNAi platform for diverse range of therapeutic areas, particularly vascular and endothelial
Contact us for more information or with a proposal, here.
Some of our current research collaborators include: Oxford University, Cambridge University, Imperial College London, Hannover Medical School, Marien Hospital Herne, University of Bochum, University Medicine Rostock, VU University Medical Centre Amsterdam, and the University of Birmingham.
Some of our industry partners have included Quark, AstraZeneca and miReven.